Arrowhead Research (ARWR) Target Price Doubled at Jefferies

February 7, 2014 7:19 AM EST
Get Alerts ARWR Hot Sheet
Price: $65.96 -1.15%

Rating Summary:
    11 Buy, 5 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 26 | New: 41
Trade Now! 
Join SI Premium – FREE
Jefferies analyst Thomas Wei doubled his price target on Arrowhead Research (NASDAQ: ARWR) - from $15 to $30 - following a positive meeting with management.

"We are becoming increasingly excited about the prospects for ARC520 in HBV and see the mid-year data in HBV patients as driving significant upside for ARWR," Wei said. "The company also plans on disclosing its liver orphan disease target and presenting preclinical animal data at an analyst meeting in late 2Q. ARWR is one of our top picks for 2014 based on the value of its RNAi platform and our increasingly positive stance on ARC520."

The firm cut FY 2014 EPS from $ ($0.62) to ($0.71) and FY 2015 EPS from $0.64 to $0.63.

For an analyst ratings summary and ratings history on Arrowhead Research click here. For more ratings news on Arrowhead Research click here.

Shares of Arrowhead Research closed at $14.54 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change, Hot Comments

Related Entities

Jefferies & Co, Thomas Wei